Microfluidic Body-on-a-Chip Gravity-Driven Flow
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current body-on-a-chip systems for drug testing face challenges such as bidirectional fluid flow difficulties, sealing issues, and the inability to accurately mimic human metabolism, leading to inefficiencies and inaccuracies in drug development.
Innovation Solution
A microfluidic device with a modular design that allows for unidirectional fluid flow using a rocking platform and a reversible sealing mechanism, enabling the creation of a low-cost, leak-free, and air bubble-free assembly that replicates human metabolism by simulating the relationship between body tissues and blood volume.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pumps and tubing are used to operate body-on-a-chip systems, then fluid flow can be controlled, but the systems become expensive and introduce errors such as air bubbles and leaking
Solution Approach 1:
The patent removes pumps and tubing from the system entirely, replacing them with a passive gravity-driven flow mechanism. The microfluidic device uses a simple reservoir and channel structure where fluid flows naturally from a higher to lower position, eliminating the need for complex active pumping components while maintaining reliable fluid control.
Solution Approach 2:
The system uses gravity as a free resource to drive fluid flow through the microchannels. The reservoir is positioned at a height that creates sufficient hydrostatic pressure to move fluid through the tissue culture chambers without requiring external energy input or mechanical actuators, making the system self-regulating and maintenance-free.
2Device complexity
If gravity driven flow is used, then the system is simpler, but the flow becomes bidirectional which creates design difficulties and changes gene expression in cell types such as endothelial cells
Solution Approach 1:
The microfluidic device incorporates an asymmetric valve structure within the channels that allows fluid to flow freely in one direction while blocking reverse flow. This asymmetric design creates a check valve effect using the device geometry itself, ensuring unidirectional flow through the tissue chambers without requiring external control mechanisms.
Solution Approach 2:
The system uses periodic tilting or rocking motion of the entire device to reset the fluid level in the reservoir, creating a rhythmic flow pattern that maintains unidirectional movement through the channels while allowing the system to remain passive and simple in structure.
3Ease of manufacture
If PDMS is used for sealing, then low-cost sealing can be achieved, but hydrophobic substances partition into PDMS making it not useful for drug testing with hydrophobic drugs
Solution Approach 1:
The patent employs disposable microfluidic chips made from materials that do not absorb hydrophobic substances. These single-use chips are sealed using methods appropriate for their material composition (such as thermal bonding for plastics or fusion for glass), eliminating the need for PDMS while maintaining cost-effectiveness through disposable rather than reusable design.
Solution Approach 2:
The device uses composite construction with inert materials such as cyclic olefin copolymer (COC), polyethylene terephthalate (PET), or glass for the microfluidic channels, which do not interact with hydrophobic drugs. These materials are sealed using techniques matched to their properties, creating a composite structure that combines chemical inertness with effective sealing.
4Reliability
If permanent sealing is used, then sealing reliability is improved, but cells cannot be introduced and localized to specific regions after sealing
Solution Approach 1:
The device is designed with pre-formed openings or access ports that are sealed after cell introduction. Cells are loaded into the microfluidic chambers through these designated access points before the final permanent seal is applied, allowing both cell introduction and reliable sealing to be achieved in sequence.
Solution Approach 2:
The sealing process is divided into stages: first, cells are introduced through open access ports; then the ports are sealed permanently using appropriate methods for the material (thermal bonding, adhesive, or fusion). This segmentation of the sealing operation allows cell introduction to occur before final sealing is applied.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device allows for the independent maturation of tissues and the simulation of human metabolism, providing a cost-effective and accurate platform for drug testing by maintaining tissue viability and functionality over extended periods.
Implementation Method 1
A microfluidic device with a modular design that allows for unidirectional fluid flow using a rocking platform
Data Source
AI summary
A microfluidic device includes a base comprising a chamber configured to receive a microfluidic component. A sealing member includes a body, an inlet reservoir, and an outlet reservoir, where the inlet reservoir and the outlet reservoir communicate with the chamber through fluid passages when the sealing member and base are removably coupled. A microfluidic component removably within the chamber includes microfluidic channels on a surface thereof and a tissue culture chamber coupled to at least one of the microfluidic channels. The microfluidic channels and the tissue culture chamber are in fluid communication with the inlet and outlet reservoirs through the fluid passages to form a fluid circuit for directing fluid from the inlet reservoir, through the tissue culture chamber, to the outlet reservoir, and from the outlet reservoir back to the inlet reservoir upon tilting the microfluidic device to a forward tilted position and to a reverse tilted position, respectively.